SFV HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Amgen Migraine Drug Aimovig Approved in Japan
Amgen Inc.’s migraine attack suppressant, Aimovig, has been granted marketing approval by the Japanese Ministry of Health, Labour and Welfare.
Quanta Subsidiary Signs Tony Hawk Endorsement Deal
Medolife Rx Inc., a subsidiary of Quanta Inc. in Burbank, has reached a brand endorsement agreement with skateboarding icon Tony Hawk.
MannKind to Co-Develop Lung Fibrosis Treatment
Mannkind Corp. has signed a collaboration agreement with Thirona Bio Inc. to further development of a new chemical owned by Thirona to treat lung fibrosis.
Amgen Lung Cancer Drug Approved by FDA
The U.S. Food and Drug Administration gave accelerated approval to Lumakras, a drug from Amgen Inc. for adult patients with non-small cell lung cancer.
LTC Sells Three Wisconsin Properties for $35 Million
Real estate investment trust LTC Properties, which specializes in health care property and senior housing investments, has announced a $35 million sale of three assisted living properties in Wisconsin.
Amgen Signs $1.25 Billion Deal to Develop Skin Treatment
Amgen Inc. on Tuesday announced a $1.25 billion deal with Kyowa Kirin Co. Ltd. to jointly develop and commercialize Kyowa’s treatment for atopic dermatitis, KHK4083.
Providence St. Joseph Hospital Chief Executive Steps Down
Kelly Linden stepped down as chief executive of Providence St. Joseph Medical Center in Burbank effective May 14.
Amgen Keeps Patent Protection for Enbrel With Supreme Court Decision
The U.S. Supreme Court declined to hear Novartis AG’s appeal of a lower court’s decision on Monday, allowing Amgen Inc. to keep its patent protection for the rheumatoid arthritis drug Enbrel until 2029.
Second Sight Shares Climb as Orion Study Shows Improved Vision
Second Sight Medical Products Inc. closed up more than 27 percent after announcing the results of a two-year study of its Orion visual prosthesis.
Amgen Stomach Cancer Drug Earns FDA Breakthrough Status
A stomach cancer drug in development by Amgen Inc. has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration.
Medtronic Launches Large-Capacity Insulin Pump Technology
Medtronic has launched its diabetes extended infusion set in some European countries.
Memory Care Facility Opens in Thousand Oaks
Assisted living facility chain Silverado Senior Living has opened its newest memory care center in Thousand Oaks, its first location in Ventura County.
Second Sight’s Argus II System Receives FDA Approval
Second Sight Medical Products announced its Argus IIs Retinal Prosthesis System was approved by the U.S. Food and Drug Administration.
Amgen to Acquire Five Prime Therapeutics for $1.9 Billion
Amgen Inc. plans to acquire Bay Area biotech company Five Prime Therapeutics for $1.9 billion in cash, or $38 per share.
Lancaster, Kaiser Permanente Partner to Open Mass Vaccination Site
The City of Lancaster, in partnership with Kaiser Permanente, will open a mass vaccination site at the Antelope Valley Fairgrounds on March 8.
Prev Next